Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer

Contributed by: Business Wire

Logo

Tags

Science

Other Science

Biotechnology

Research

Pharmaceutical

Oncology

Health

Health Technology

Christoph Korpus

More Like This

Christoph Korpus, PhD, MBA, Chief Business Officer, Byondis

Byondis Appoints Christoph Korpus, PhD, MBA, as Chief Business Officer

Louis Denis, M.D., Chief Medical Officer, Byondis (Photo: Business Wire)

Byondis Appoints Louis Denis, M.D., as Chief Medical Officer

Byondis to Present Data from its Novel ADC Technology Platforms at the American Society for Cancer Research Meeting 2026

PR Newswire associated0

Bio X Cell Announces CEO Appointment

PR Newswire associated0

mAbxience Appoints Jurgen Van Broeck as New CEO

Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer

Dr. Hubert Scholze, Chief Business Officer, Rezon Bio

Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer to Accelerate Global Commercial Expansion

Louis Denis, MD, Chief Medical Officer, Byondis

Byondis Announces First Patient Dosed in Phase 1 Clinical Trial of Novel SIRPα-Directed Monoclonal Antibody BYON4228 in Patients With Advanced or Metastatic Solid Tumors